Phesi

📢 Our Founder and President Gen Li, PhD, MBA recently spoke to The Medicine Maker about how #DigitalTwinTechnology is transforming clinical trials. 🧪 In the article, Gen delves into regulatory obstacles and the benefits of digital twins over placebo control arms. 👇To read the full article, click below: https://lnkd.in/ezBD-4P8 #ClinicalTrials #AI #DigitalTwins #Data #PatientCare

Our Founder and President Gen Li, PhD, MBA sat down with Targeted Oncology to discuss #digitaltwins and SOC treatment for patients with chronic GvHD. In the interview, Gen reveals the finding of @Phesi’s recent cGvHD study and delves into the benefits of using digital twin technology in real-world #clinialtrials. 💊 📖 Read the full article here: https://lnkd.in/e5cam923 #ClinicalTrials #AI #DigitalTwins #Data

📣 Our Founder and President Gen Li, PhD, MBA discusses how digital twins have opened up a new frontier for regulatory agencies in the #ClinicalTrials industry in the latest issue of Applied Clinical Trials Magazine. In the article, Gen uncovers how #ClinicalDevelopment organisations can accelerate adoption of digital twins by exploring real-world data and developing integration approaches that can be discussed early with regulatory agencies. 🔬 📖 For more, read full article here: https://lnkd.in/efWTw2WF #AI #DigitalTwins #Data

I’m thrilled to announce that we will be showcasing Phesi’s award-winning Trial Accelerator™ platform at #DPHARM2024. Our team is honored to have received Frost & Sullivan’s 2024 Enabling Technology Leadership Award for our groundbreaking AI-driven solution, revolutionizing clinical development. According to Norazah Bachok, best practices research analyst at Frost & Sullivan, "Phesi leads clients towards innovative trials and faster cures, solidifying its position as a trailblazer in AI-enabled patient-centric data software services." Trial Accelerator has consistently proven to reduce amendments and shorten cycle times, aiding in the delivery of life-saving medicines. Visit booth #32 to learn how we can help transform your clinical trials and enhance operational efficiencies. Book a meeting with us: https://lnkd.in/eiPeXnxy #clinicaltrials #clinicaldevelopment #bigdata #artificialintelligence #protocoldesign #investigatorsites #patientcentric

I'm thrilled to share that Phesi has been honored with Frost & Sullivan’s 2024 Global AI-Enabled Clinical Trial Design Enabling Technology Leadership Award. This recognition underscores our commitment to innovation and industry advancement over the past 20 years. Aarti Natu Chitale from Frost & Sullivan highlighted how our Trial Accelerator Platform is transforming clinical development by enhancing efficiency in trial design and investigator site selection for pharmaceutical and biotech clients. Learn more in the full report: https://lnkd.in/dNaDmJXn #clinicaltrials #clinicaldevelopment #protocoldesign #clinicaltrialdesign #bigdata #artificialintelligence #innovation

📣 Our Founder and President Gen Li, PhD, MBA uncovers how data can be applied to improve the #ClinicalTrials industry in the latest issue of Samedan Ltd’s International Clinical Trials. In the article, Gen delves into how new techniques such as predictive data analytics, digital patient profiles, and digital twins can improve patient-centricity and investigator site performance – delivering smarter trials, and faster cures. 💊 📖 Check out the full article here: https://lnkd.in/eW9khThp #ClinicalDevelopment #AI #DigitalTwins #Data

Latest analysis by leading clinical development analytics company Phesi, released ahead of this year’s American Society of Clinical Oncology (ASCO) annual meeting, analysed 11,755 Phase I, II and III oncology clinical trial sites open for recruitment since 2019. It showed a 49% increase in recruiting oncology investigator sites. Phesi president, Dr Gen Li, PhD, MBA, PhD, MBA warned that, although cancer remained an area of high investment in the pharmaceutical industry, pressure was increasing on investigator sites. Read more: https://lnkd.in/gBmtKmbc #LabNews #oncology #cancer #phesi #pharma

Our Founder and President Gen Li, PhD, MBA sat down with Moe Alsumidaie of The Clinical Trial Vanguard to discuss how a data-driven approach to clinical development can streamline trial design, reduce costs, and bring new treatments to market faster. 💊 In the interview, Gen discusses the next steps for expanding Phesi’s digital patient profile catalog and how sponsors can maintain high privacy standards when handling patient data. 👨💻 🎙️ Check out the full interview here: https://lnkd.in/eejMDe2G #ClinicalTrials #ClinicalDevelopment #AI #Data #DigitalTwins

The latest episode of the DDW Highlights podcast, narrated by Megan Thomas, is now available. Clinical trial news has caught our attention this week. Despite the revelation from Phesi that a third of clinical trials fail at Phase II, DDW has reported positive human trial updates on therapeutics for myasthenia gravis, non-small cell lung cancer, Marburg virus, and Parkinson’s disease. https://lnkd.in/e-pnXacG #clinicaltrials #drugdiscovery #podcast

A new study by Phesi has found that #type2diabetes has knocked COVID-19 out of the top five most researched diseases in the world. Find out more: https://hubs.la/Q02Gz_1t0